CRD-1968099

N/A

Report date: 2023/05/22 10:18:09

Base Information

Drug NameCRD-1968099
Drug Alias NameCRD-1968099
ClassificationSmall molecules
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 inhibitors
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChordia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A